Market Research Industry Reports

Thermo Fisher Scientific Inc (TMO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • DESCRIPTION
  • TABLE OF CONTENTS
  • RELATED REPORTS
  • SAMPLE REQUEST
  • REVIEWS
Summary

Thermo Fisher Scientific Inc (Thermo Fisher) is a provider of equipment, analytical instruments, reagents and consumables, software and services to tackle complex analytical challenges in research, diagnostics and clinical laboratories. It offers solutions for cellular analysis and biology, flow cytometry and synthetic biology. The companys product portfolio includes technologies for mass spectrometry, electron microscopy, genetic sequencing, protein and molecular biology research. The company serves pharmaceutical and biotech companies, academic and research institutions, clinical diagnostic labs, and government agencies; and environmental, industrial quality and process control sectors. It sells its products and services through direct sales force, e-commerce and third-party distributors in the Americas, Asia-Pacific and Europe. Thermo Fisher is headquartered in Waltham, Massachusetts, the US.

Thermo Fisher Scientific Inc (TMO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 7
List of Figures 9
Thermo Fisher Scientific Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 10
Thermo Fisher Scientific Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 11
Thermo Fisher Scientific Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 12
Thermo Fisher Scientific Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 13
Thermo Fisher Scientific Inc, Medical Devices Deals, 2012 to YTD 2018 14
Thermo Fisher Scientific Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 15
Thermo Fisher Scientific Inc, Pharmaceuticals & Healthcare, Deal Details 20
Asset Purchase 20
Patheon Acquires API Manufacturing Site, South Carolina from Roche 20
Venture Financing 21
IntegenX Secures USD10 Million in Financing 21
IntegenX Raises US$49 Million In Venture Financing 22
Private Equity 23
GTCR Completes Acquisition of Cole-Parmer from Thermo Fisher for USD480 Million 23
StoneCalibre Acquires Anatrace From Affymetrix 24
OpenGate Capital Acquires Laboratory Workstations Business From Thermo Fisher 25
Partnerships 26
Affymetrix Enters into Licensing Agreement with Peptide Groove 26
diaDexus Enters Into Licensing Agreement With Thermo Fisher Scientific 27
Medicyte Enters Into Licensing Agreement With Life Technologies For Next Generation Upcyte Cells 28
Thermo Fisher Scientific Enters Into Licensing Agreement With Fujirebio For Procalcitonin 29
Evoke Pharma Enters into Agreement with Thermo Fisher Scientific 30
Genomics England, Inivata and Thermo Fisher Enter into Agreement 31
Synthego Enters into Agreement with Thermo Fisher 32
Thermo Fisher Scientific Partners with National Institute for Bioprocessing Research and Training 33
Thermo Fisher Scientific Enters into Agreement with West China Hospital of Sichuan University 34
Achaogen Enters into Agreement with Microgenics 35
Patheon Enters into Co-Development Agreement with Grunenthal 36
Thermo Fisher Scientific Enters into Agreement with Karolinska Institute 37
Singapore General Hospital Enters into Agreement with Thermo Fisher Scientific 38
Stem Cell Theranostics Enters into Research Agreement with Thermo Fisher Scientific 39
Horizon Discovery Enters into Agreement with Thermo Fisher Scientific 40
Horizon Discovery Enters Into Marketing Agreement With Thermo Fisher 41
AstraZeneca Enters into Research Agreement with Thermo Fisher Scientific 42
Thermo Fisher Scientific Enters into Distribution Agreement with Cynvenio Biosystems 43
Affymetrix Enters Into Integration Agreement With CollabRx 44
Copan Diagnostics Enters Into Distribution Agreement With Thermo Fisher For WASP 45
Life Technologies Enters Into Distribution Agreement With IntegenX For GlobalFiler Express Chemistry 46
Life Technologies Extends R&D Agreement With Dnavec For CytoTune-iPS 2.0 Sendai Reprogramming Kit 47
Life Technologies Enters Into Distribution Agreement With Advanced Cell Diagnostics 48
VWR International Enters Into Distribution Agreement With Thermo Fisher Scientific 49
Thermo Fisher Scientific Enters Into Distribution Agreement With Mitsui Knowledge Industry For Lipidomics Software 50
Proteome Sciences Enters Into Co-Development Agreement With Thermo Fisher 51
Ingenuity Systems Enters Into Co-Promotion Agreement With Affymetrix For Research Tools 52
Olfactory Biosciences Enters Into Distribution Agreement With Fisher HealthCare For Noxo Products 53
Thermo Fisher Scientific Enters Into Research Agreement With University of Birmingham 54
Affymetrix Enters Into Co-Marketing Agreement With GenoSplice For GeneChip Human Transcriptome Array 2.0 55
TAP Biosystems Enters Into Co-Development Agreement With Life Technologies For Protein Expression Platform 56
Affymetrix Enters Into Research Agreement With Centre For Proteomic And Genomic Research 57
Genedata Enters Into Technology Integration Agreement With Life Technologies 58
Thermo Fisher Enters Into Co-Development Agreement With Immundiagnostik 59
Life Technologies Enters Into Distribution Agreement With Sino Biological 60
Thermo Fisher Enters Into An Agreement With Princeton University 61
Life Technologies Enters Into Joint Venture Agreement With Structural Genomics Consortium 62
Refine Technology Enters Into Technology Integration Agreement With Thermo Fisher Scientific 63
Life Technologies Enters Into Co-Marketing Agreement With Douglas Scientific 64
Life Technologies Enters Into Co-Development Agreement With Boston Childrens Hospital 65
Life Technologies Enter Into Agreement With University Of North Texas Health Science Center For DNA Analyses 66
Hospital for Sick Children Enters Into Co-Development Agreement With Life Technologies 67
Life Technologies Amends Co-Marketing Agreement With Cellular Dynamics International 68
Life Technologies Enters Into Co-Development Agreement With OpGen 69
Almac Enters Into Distribution Agreement With Affymetrix For Xcel Array 70
Partek Enters Into Technology Integration Agreement With Life Technologies 71
FEI Enters Into R&D Agreement With NIH 72
Thermo Fisher Scientific Enters Into Co-Marketing Agreement With PREMIER Biosoft 73
Licensing Agreements 74
Juno Therapeutics Enters into Licensing Agreement with Thermo Fisher Scientific 74
Life Technologies Enters into Licensing Agreement with Genovis 75
Adaptimmune Therapeutics Enters into Licensing Agreement with Thermo Fisher Scientific 76
MabVax Therapeutics Enters into Licensing Agreement with Life Technologies 77
Life Technologies Enters Into Licensing Agreement With Suzhou Ribo Life Sciences For siRNA Therapeutics 78
Thermo Fisher Scientific Enters into Licensing Agreement with Plant Bioscience 79
Thermo Fisher Scientific Enters into Licensing Agreement with Sygnis 80
Accellta Enters into Licensing Agreement with Thermo Fisher Scientific 81
Thermo Fisher Enters into Licensing Agreement with ToolGen for CRISPR/Cas9 82
Cellectis Enters into Licensing Agreement with Thermo Fisher Scientific for Gene Editing Technology 83
BGI Enters Into Licensing Agreement With Life Technologies 84
Life Technologies Enters Into Licensing Agreement With iGenomics For Ion Proton Next-Generation Sequencers 85
Life Technologies Enters Into Licensing Agreement With Novartis 86
Cellular Dynamics Enters Into Licensing Agreement With Life Technologies And Sigma-Aldrich 87
Cellular Dynamics International Enters Into Licensing Agreement With Life Technologies For TAL Effector Technology 88
Life Technologies Enters Into Licensing Agreement With ToolGen For TAL Effector Technology 89
Adaptimmune Enters Into Licensing Agreement With Life Technologies 90
Thermo Fisher Scientific Enter Into Licensing Agreement With Protein Metric For Proteomics Software 91
ATCC Enters Into Licensing Agreement With Life Technologies For GFP Technology 92
Life Technologies Enters Into Licensing Agreement With iPS Academia Japan 93
Cambridge Research Biochemicals Extends Licensing Agreement With Life Technologies 94
Equity Offering 95
Thermo Fisher Scientific Prices Public Offering of Shares for USD1.5 Billion 95
Patheon Completes IPO 97
Affymetrix to Raise USD50 Million in Private Placement of Shares 98
Thermo Fisher Scientific Announces Private Placement Of Common Stock For US$500 Million 99
Thermo Fisher Completes Public Offering Of Shares For US$2.53 Billion 100
Patheon Completes Rights Offering Of Shares For US$30 Million 102
Affymetrix Files Registration Statement For Public Offering Of Securities For US$200 Million 103
Debt Offering 104
Thermo Fisher Scientific Raises USD750 Million in Public Offering of 3.2% Notes Due 2027 104
Thermo Fisher Scientific Raises USD750 Million in Public Offering of 4.1% Notes Due 2047 106
Thermo Fisher Scientific Prices Public Offering of 1.45% Notes Due 2027 for USD530 Million 108
Thermo Fisher Scientific Raises USD1.2 Billion in Public Offering of Notes 110
Thermo Fisher Scientific Raises USD1.12 Billion in Public Offering of 1.375% Notes Due 2028 112
Thermo Fisher Scientific Raises USD1 Billion in Public Offering of 3% Notes Due 2023 114
Thermo Fisher Scientific Raises USD350 Million in Public Offering of 3.65% Notes Due 2025 115
Thermo Fisher Scientific Raises USD450 Million in Public Offering of 2.150% Notes Due 2018 116
Thermo Fisher Scientific Raises USD457 Million in Public Offering of 1.5% Notes Due 2020 117
Thermo Fisher Scientific Raises USD549.4 Million in Public Offering of 2.15% Notes Due 2022 119
Patheon Raises USD450 Million in Private Placement of 7.5% Notes Due 2022 121
Thermo Fisher Scientific Completes Public Offering Of Notes Due 2044 For US$400 Million 122
Thermo Fisher Scientific Completes Public Offering Of Notes Due 2024 For US$1 Billion 124
Thermo Fisher Scientific Completes Public Offering Of Notes Due 2017 For US$900 Million 126
Thermo Fisher Scientific Completes Public Offering Of Notes Due 2019 For US$900 Million 128
Thermo Fisher Scientific Completes Public Offering Of Senior Notes Due 2018 For US$500 Million 130
Thermo Fisher Scientific Completes Public Offering Of Senior Notes Due 2023 For US$800 Million 132
Affymetrix Completes Public Offering Of Notes Due 2019 For US$105 Million 134
Asset Transactions 136
Perrigo Acquires Mexican Operations of Patheon for USD34 Million 136
GE Healthcare Completes Acquisition Of Cell Culture, Gene Modulation And Magnetic Beads Businesses Of Thermo Fisher Scientific For US$1.06 Billion 137
Bellwyck Packaging Solutions Acquires Clinical Packaging And Distribution Services Business From Patheon 138
Acquisition 139
Thermo Fisher Scientific Acquires 99% Stake in Patheon for USD7.2 Billion 139
Thermo Fisher Scientific Acquires Finesse Solutions 141
Thermo Fisher Scientific to Acquire MTI-GlobalStem 142
Thermo Fisher Scientific Acquires FEI for USD4.2 Billion 143
Thermo Fisher Scientific Acquires Alfa Aesar for USD403 Million 145
LIVIA to Acquire Patheon Capua 146
Perrigo Company Acquires Banner Pharmacaps from Patheon for USD36.4 Million 147
Patheon Acquires IRIX Pharma 148
Patheon Acquires Agere Pharma 149
Thermo Fisher Scientific Acquires Advanced Scientifics for USD289 Million 150
JLL/Delta Patheon Completes Acquisition Of Patheon For US$2.6 Billion 151
Thermo Fisher Scientific Completes Acquisition Of Life Technologies For US$13.6 Billion 153
Life Technologies Acquires Life Science Korea, Instruments Distributor 156
Life Technologies Acquires BAC 157
Patheon Completes Acquisition Of Banner Pharmacaps From Vion For US$255 Million 158
Life Technologies Acquires Compendia Bioscience, Bioinformatics Company 160
Life Technologies Acquires Navigenics 161
Affymetrix Completes Acquisition Of eBioscience For US$315 Million 162
Thermo Fisher Scientific Acquires Doe & Ingalls Management For US$175 Million 164
IntegenX Acquires SV, Provider Of DNA Identification Consumable Products, From GE Healthcare Bio-Sciences 165
Thermo Fisher Scientific Inc - Key Competitors 166
Thermo Fisher Scientific Inc - Key Employees 167
Thermo Fisher Scientific Inc - Locations And Subsidiaries 169
Head Office 169
Other Locations & Subsidiaries 169
Joint Venture 173
Recent Developments 174
Strategy And Business Planning 174
Mar 16, 2018: Thermo Fisher Scientific Announces Plans To Build State-Of-The-Art Pharma Services Facility In Rheinfelden 174
Financial Announcements 175
Jan 31, 2018: Thermo Fisher Scientific Reports Fourth Quarter and Full Year 2017 Results 175
Oct 25, 2017: Thermo Fisher Scientific Reports Third Quarter 2017 Results 177
Jul 26, 2017: Thermo Fisher Scientific Reports Second Quarter 2017 Results 180
Apr 26, 2017: Thermo Fisher Scientific Reports First Quarter 2017 Results 182
Jan 31, 2017: Thermo Fisher Scientific Reports Fourth Quarter and Full Year 2016 Results 184
Corporate Communications 186
Mar 01, 2017: Thermo Fisher Scientific Elects New Director to Board 186
Legal and Regulatory 187
Jan 23, 2017: ISO 17025 Accreditation for Microbiology Manufacturing Site Offers Increased Confidence to Microbiology Testing Laboratories 187
Product News 188
Dec 07, 2017: New Myeloid Research Assay Combines Simultaneous DNA and RNA Analysis of Most Relevant Hematologic Cancer Driver Genes 188
Nov 27, 2017: Expanded Genome Editing Tool Kit Supports Every Step in Researchers Workflow 189
Oct 23, 2017: New Unrivalled Capabilities Take GC-MS to the Next Level of Performance 190
Oct 19, 2017: Thermo Fisher Scientific and Wellcome Trust Sanger Institute Announce the Axiom Africa Array for Medical and Population Genomics 191
Sep 25, 2017: Next-Generation Media System Provides the Highest In Vitro Survival of Neurons 192
Aug 07, 2017: Industrys First Dedicated Cryo-DualBeam System Automates Preparation of Frozen, Biological Samples 193
Aug 07, 2017: Thermo Fisher Scientific Advances Cryo-EM Leadership to Drive Structural Biology Discoveries 194
Aug 07, 2017: Thermo Fisher Scientifics New Talos F200i S/TEM Delivers Flexible, High-Performance Imaging 195
Jul 19, 2017: Thermo Fisher Scientific Announces Asia Precision Medicine Research Array for Regional Screening Initiatives 196
Jul 18, 2017: New Thermo Scientific Samco Leakproof Vials Offer Enhanced Sample and User Safety 197
Jul 11, 2017: New Universal RNase-, DNase- and Human DNA-free Containers Designed for Enhanced Sample Safety and Viability 198
Jun 05, 2017: New Tribrid Mass Spectrometer Delivers New Levels of Power and Performance for Protein and Small Molecule Characterization 199
Jun 05, 2017: New Software and Cloud-based Solutions Let Scientists Gain More Insight From Their Data 200
Jun 05, 2017: Next-Generation Triple Quadrupole Mass Spectrometers Deliver High Precision for Quantitative Workflows 201
Jun 05, 2017: Ready-to-Use Mass Spectrometric Kit Simplifies Insulin Bioanalysis Workflows 202
Jun 05, 2017: Thermo Fisher Scientific Raises the Bar in Mass Spectrometry Innovation at ASMS 2017 203
May 15, 2017: Thermo Fisher Scientific Strengthens Portfolio of Endotoxin-Free Plasmid DNA Isolation Kits 205
May 03, 2017: Automating Blood Cell Washing Applications to Boost Laboratory Performance 206
Apr 17, 2018: Thermo Fisher Scientific Showcases Bioprocessing Workflow Solutions at INTERPHEX 207
Mar 15, 2017: Thermo Fisher Scientific Introduces the QuantStudio 5 Real-Time PCR System for the Modern Forensic Laboratory 208
Mar 15, 2017: Thermo Fisher Scientific Announces First-Ever Cloud-Based Application for Connectivity to Electronic Pipettes 209
Feb 28, 2018: Thermo Fisher Supplies Analytical Instruments to World Anti-Doping Agency Laboratory in South Korea 210
Feb 05, 2018: Thermo Fisher Scientific Launches Axiom Microbiome Array for Research 211
Feb 02, 2017: New Media Improves Performance in Latest Pluripotent Stem Cell Applications 212
Jan 29, 2018: New, Automated UV-Visible Spectrophotometers are Designed for Todays Modern Lab 213
Jan 08, 2018: Thermo Fisher Scientific Expands Oncomine Portfolio for Liquid Biopsy and Immuno-oncology Clinical Research 214
Other Significant Developments 216
Apr 23, 2018: Thermo Fisher Scientific Announces $50 Million Investment to Enhance Biologics Capabilities 216
Mar 29, 2018: Thermo Fisher Scientific Sponsors Precision Medicine Summit in China 217
Mar 21, 2018: Thermo Fisher says UK job cuts not Brexit-related 218
Jan 31, 2018: Thermo Fisher Scientific Uses Tax Reform Benefit to Make Additional Investments in Colleagues, Customers and Communities 219
Sep 27, 2017: Thermo Fisher Scientific to Participate in Capitol Hill Briefing on Precision Medicine Advancements 220
Jul 31, 2017: New Lab-Grade Undercounter Refrigerators Use Redundant Cooling Technology to Maintain Optimal Storage Conditions 221
Jul 10, 2017: Thermo Fisher Scientific and SRI International Collaborate to Enhance Small Molecule Research 222
Jun 15, 2017: Thermo Fisher Scientific Expands Access to Genome Editing with Hands-On Workshop 223
Appendix 224
Methodology 224
About GlobalData 224
Contact Us 224
Disclaimer 224

List Of Tables

List of Tables
Thermo Fisher Scientific Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Thermo Fisher Scientific Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 10
Thermo Fisher Scientific Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 11
Thermo Fisher Scientific Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 12
Thermo Fisher Scientific Inc, Deals By Therapy Area, 2012 to YTD 2018 13
Thermo Fisher Scientific Inc, Medical Devices Deals, 2012 to YTD 2018 14
Thermo Fisher Scientific Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 15
Patheon Acquires API Manufacturing Site, South Carolina from Roche 20
IntegenX Secures USD10 Million in Financing 21
IntegenX Raises US$49 Million In Venture Financing 22
GTCR Completes Acquisition of Cole-Parmer from Thermo Fisher for USD480 Million 23
StoneCalibre Acquires Anatrace From Affymetrix 24
OpenGate Capital Acquires Laboratory Workstations Business From Thermo Fisher 25
Affymetrix Enters into Licensing Agreement with Peptide Groove 26
diaDexus Enters Into Licensing Agreement With Thermo Fisher Scientific 27
Medicyte Enters Into Licensing Agreement With Life Technologies For Next Generation Upcyte Cells 28
Thermo Fisher Scientific Enters Into Licensing Agreement With Fujirebio For Procalcitonin 29
Evoke Pharma Enters into Agreement with Thermo Fisher Scientific 30
Genomics England, Inivata and Thermo Fisher Enter into Agreement 31
Synthego Enters into Agreement with Thermo Fisher 32
Thermo Fisher Scientific Partners with National Institute for Bioprocessing Research and Training 33
Thermo Fisher Scientific Enters into Agreement with West China Hospital of Sichuan University 34
Achaogen Enters into Agreement with Microgenics 35
Patheon Enters into Co-Development Agreement with Grunenthal 36
Thermo Fisher Scientific Enters into Agreement with Karolinska Institute 37
Singapore General Hospital Enters into Agreement with Thermo Fisher Scientific 38
Stem Cell Theranostics Enters into Research Agreement with Thermo Fisher Scientific 39
Horizon Discovery Enters into Agreement with Thermo Fisher Scientific 40
Horizon Discovery Enters Into Marketing Agreement With Thermo Fisher 41
AstraZeneca Enters into Research Agreement with Thermo Fisher Scientific 42
Thermo Fisher Scientific Enters into Distribution Agreement with Cynvenio Biosystems 43
Affymetrix Enters Into Integration Agreement With CollabRx 44
Copan Diagnostics Enters Into Distribution Agreement With Thermo Fisher For WASP 45
Life Technologies Enters Into Distribution Agreement With IntegenX For GlobalFiler Express Chemistry 46
Life Technologies Extends R&D Agreement With Dnavec For CytoTune-iPS 2.0 Sendai Reprogramming Kit 47
Life Technologies Enters Into Distribution Agreement With Advanced Cell Diagnostics 48
VWR International Enters Into Distribution Agreement With Thermo Fisher Scientific 49
Thermo Fisher Scientific Enters Into Distribution Agreement With Mitsui Knowledge Industry For Lipidomics Software 50
Proteome Sciences Enters Into Co-Development Agreement With Thermo Fisher 51
Ingenuity Systems Enters Into Co-Promotion Agreement With Affymetrix For Research Tools 52
Olfactory Biosciences Enters Into Distribution Agreement With Fisher HealthCare For Noxo Products 53
Thermo Fisher Scientific Enters Into Research Agreement With University of Birmingham 54
Affymetrix Enters Into Co-Marketing Agreement With GenoSplice For GeneChip Human Transcriptome Array 2.0 55
TAP Biosystems Enters Into Co-Development Agreement With Life Technologies For Protein Expression Platform 56
Affymetrix Enters Into Research Agreement With Centre For Proteomic And Genomic Research 57
Genedata Enters Into Technology Integration Agreement With Life Technologies 58
Thermo Fisher Enters Into Co-Development Agreement With Immundiagnostik 59
Life Technologies Enters Into Distribution Agreement With Sino Biological 60
Thermo Fisher Enters Into An Agreement With Princeton University 61
Life Technologies Enters Into Joint Venture Agreement With Structural Genomics Consortium 62
Refine Technology Enters Into Technology Integration Agreement With Thermo Fisher Scientific 63
Life Technologies Enters Into Co-Marketing Agreement With Douglas Scientific 64
Life Technologies Enters Into Co-Development Agreement With Boston Childrens Hospital 65
Life Technologies Enter Into Agreement With University Of North Texas Health Science Center For DNA Analyses 66
Hospital for Sick Children Enters Into Co-Development Agreement With Life Technologies 67
Life Technologies Amends Co-Marketing Agreement With Cellular Dynamics International 68
Life Technologies Enters Into Co-Development Agreement With OpGen 69
Almac Enters Into Distribution Agreement With Affymetrix For Xcel Array 70
Partek Enters Into Technology Integration Agreement With Life Technologies 71
FEI Enters Into R&D Agreement With NIH 72
Thermo Fisher Scientific Enters Into Co-Marketing Agreement With PREMIER Biosoft 73
Juno Therapeutics Enters into Licensing Agreement with Thermo Fisher Scientific 74
Life Technologies Enters into Licensing Agreement with Genovis 75
Adaptimmune Therapeutics Enters into Licensing Agreement with Thermo Fisher Scientific 76
MabVax Therapeutics Enters into Licensing Agreement with Life Technologies 77
Life Technologies Enters Into Licensing Agreement With Suzhou Ribo Life Sciences For siRNA Therapeutics 78
Thermo Fisher Scientific Enters into Licensing Agreement with Plant Bioscience 79
Thermo Fisher Scientific Enters into Licensing Agreement with Sygnis 80
Accellta Enters into Licensing Agreement with Thermo Fisher Scientific 81
Thermo Fisher Enters into Licensing Agreement with ToolGen for CRISPR/Cas9 82
Cellectis Enters into Licensing Agreement with Thermo Fisher Scientific for Gene Editing Technology 83
BGI Enters Into Licensing Agreement With Life Technologies 84
Life Technologies Enters Into Licensing Agreement With iGenomics For Ion Proton Next-Generation Sequencers 85
Life Technologies Enters Into Licensing Agreement With Novartis 86
Cellular Dynamics Enters Into Licensing Agreement With Life Technologies And Sigma-Aldrich 87
Cellular Dynamics International Enters Into Licensing Agreement With Life Technologies For TAL Effector Technology 88
Life Technologies Enters Into Licensing Agreement With ToolGen For TAL Effector Technology 89
Adaptimmune Enters Into Licensing Agreement With Life Technologies 90
Thermo Fisher Scientific Enter Into Licensing Agreement With Protein Metric For Proteomics Software 91
ATCC Enters Into Licensing Agreement With Life Technologies For GFP Technology 92
Life Technologies Enters Into Licensing Agreement With iPS Academia Japan 93
Cambridge Research Biochemicals Extends Licensing Agreement With Life Technologies 94
Thermo Fisher Scientific Prices Public Offering of Shares for USD1.5 Billion 95
Patheon Completes IPO 97
Affymetrix to Raise USD50 Million in Private Placement of Shares 98
Thermo Fisher Scientific Announces Private Placement Of Common Stock For US$500 Million 99
Thermo Fisher Completes Public Offering Of Shares For US$2.53 Billion 100
Patheon Completes Rights Offering Of Shares For US$30 Million 102
Affymetrix Files Registration Statement For Public Offering Of Securities For US$200 Million 103
Thermo Fisher Scientific Raises USD750 Million in Public Offering of 3.2% Notes Due 2027 104
Thermo Fisher Scientific Raises USD750 Million in Public Offering of 4.1% Notes Due 2047 106
Thermo Fisher Scientific Prices Public Offering of 1.45% Notes Due 2027 for USD530 Million 108
Thermo Fisher Scientific Raises USD1.2 Billion in Public Offering of Notes 110
Thermo Fisher Scientific Raises USD1.12 Billion in Public Offering of 1.375% Notes Due 2028 112
Thermo Fisher Scientific Raises USD1 Billion in Public Offering of 3% Notes Due 2023 114
Thermo Fisher Scientific Raises USD350 Million in Public Offering of 3.65% Notes Due 2025 115
Thermo Fisher Scientific Raises USD450 Million in Public Offering of 2.150% Notes Due 2018 116
Thermo Fisher Scientific Raises USD457 Million in Public Offering of 1.5% Notes Due 2020 117
Thermo Fisher Scientific Raises USD549.4 Million in Public Offering of 2.15% Notes Due 2022 119
Patheon Raises USD450 Million in Private Placement of 7.5% Notes Due 2022 121
Thermo Fisher Scientific Completes Public Offering Of Notes Due 2044 For US$400 Million 122
Thermo Fisher Scientific Completes Public Offering Of Notes Due 2024 For US$1 Billion 124
Thermo Fisher Scientific Completes Public Offering Of Notes Due 2017 For US$900 Million 126
Thermo Fisher Scientific Completes Public Offering Of Notes Due 2019 For US$900 Million 128
Thermo Fisher Scientific Completes Public Offering Of Senior Notes Due 2018 For US$500 Million 130
Thermo Fisher Scientific Completes Public Offering Of Senior Notes Due 2023 For US$800 Million 132
Affymetrix Completes Public Offering Of Notes Due 2019 For US$105 Million 134
Perrigo Acquires Mexican Operations of Patheon for USD34 Million 136
GE Healthcare Completes Acquisition Of Cell Culture, Gene Modulation And Magnetic Beads Businesses Of Thermo Fisher Scientific For US$1.06 Billion 137
Bellwyck Packaging Solutions Acquires Clinical Packaging And Distribution Services Business From Patheon 138
Thermo Fisher Scientific Acquires 99% Stake in Patheon for USD7.2 Billion 139
Thermo Fisher Scientific Acquires Finesse Solutions 141
Thermo Fisher Scientific to Acquire MTI-GlobalStem 142
Thermo Fisher Scientific Acquires FEI for USD4.2 Billion 143
Thermo Fisher Scientific Acquires Alfa Aesar for USD403 Million 145
LIVIA to Acquire Patheon Capua 146
Perrigo Company Acquires Banner Pharmacaps from Patheon for USD36.4 Million 147
Patheon Acquires IRIX Pharma 148
Patheon Acquires Agere Pharma 149
Thermo Fisher Scientific Acquires Advanced Scientifics for USD289 Million 150
JLL/Delta Patheon Completes Acquisition Of Patheon For US$2.6 Billion 151
Thermo Fisher Scientific Completes Acquisition Of Life Technologies For US$13.6 Billion 153
Life Technologies Acquires Life Science Korea, Instruments Distributor 156
Life Technologies Acquires BAC 157
Patheon Completes Acquisition Of Banner Pharmacaps From Vion For US$255 Million 158
Life Technologies Acquires Compendia Bioscience, Bioinformatics Company 160
Life Technologies Acquires Navigenics 161
Affymetrix Completes Acquisition Of eBioscience For US$315 Million 162
Thermo Fisher Scientific Acquires Doe & Ingalls Management For US$175 Million 164
IntegenX Acquires SV, Provider Of DNA Identification Consumable Products, From GE Healthcare Bio-Sciences 165
Thermo Fisher Scientific Inc, Key Competitors 166
Thermo Fisher Scientific Inc, Key Employees 167
Thermo Fisher Scientific Inc, Subsidiaries 169
Thermo Fisher Scientific Inc, Joint Venture 173

List Of Figures

List of Figures
Thermo Fisher Scientific Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Thermo Fisher Scientific Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Thermo Fisher Scientific Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Thermo Fisher Scientific Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Thermo Fisher Scientific Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 10
Thermo Fisher Scientific Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 11
Thermo Fisher Scientific Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 12
Thermo Fisher Scientific Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 13
Thermo Fisher Scientific Inc, Medical Devices Deals, 2012 to YTD 2018 14

Thermo Fisher Scientific Inc (TMO) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Thermo Fisher Scientific Inc (Thermo Fisher) is a provider of equipment, analytical instruments, reagents and consumables, software and services to tackle complex analytical challenges in research, diagnostics and clinical laboratories.

USD 250View Report

Global Thermostats for Underfloor Heating Market Research Report 2018

Thermostats for Underfloor Heating Report by Material, Application, and Geography Global Forecast to 2022 is a professional and in-depth research report on the worlds major regional market conditions, focusing

USD 2850View Report

Thermo Fisher Scientific Inc (TMO) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Thermo Fisher Scientific Inc (Thermo Fisher) is a provider of equipment, analytical instruments, reagents and consumables, software and services to tackle complex analytical challenges in research, diagnostics and clinical laboratories.

USD 250View Report

2018 Thermo Fisher: Market Shares and Competitive Position by Product and Country--Performance, Capabilities, Goals and Strategies in the Global Diagnostics Industry

This unique market intelligence report provides information not available from any other published source. The report includes diagnostics sales and market share estimates by product and country for Thermo Fisher

USD 4250View Report

Your are not allow to send sample request
Fill The Form For Sample Request
Full Name :*
Bussiness Email: *
Email: *
Country :*
Contact No.*
Alternate No.
Note.:*Kindly provide us with your company id and get the sample reports at the earliest.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    USD 250
  • Site Licence    USD 500
  • Enterprise Wide Licence    USD 750
$ 250

Reports Details

Published Date : Apr 2018
No. of Pages :224
Country :United States of America
Category :Pharmaceuticals and Healthcare
Publisher :GlobalData
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube